City
Epaper

Research protocol on Ayurvedic treatment of COVID-19 by team of doctors from Pune, published in reputed international journal

By ANI | Updated: December 10, 2020 12:30 IST

A paper on an ayurvedic protocol designed by a team of doctors from Pune led by Dr Suresh Patankar has been published in a reputed international journal.

Open in App

A paper on an ayurvedic protocol designed by a team of doctors from Pune led by Dr Suresh Patankar has been published in a reputed international journal.

This could be the first instance where Nature's Trial Journal which is internationally accepted for validated publications in medical research, has published an Ayurvedic protocol. The journal committee of Savitribai Phule Pune University too has testified to this. This endorses the fact that, with due efforts, in the current times, ayurvedic science can easily prove to be evidence based.

The science of ayurveda mentions several remedies that could be used during a pandemic/epidemic. As there are no test parameters according to modern medicine that could validate these medicines/constituents, such medicinal constituents did not get necessary/authorized approvals. Also, most of the time clinical trials based on modern test parameters have not been conducted on such medicines.

Under such circumstances the AMAI Trust and Ace Hospital, Pune took the challenge head on. The institutions since the past few years were already engaged in research on medicines of a similar kind. Many subjects were found to benefit by these medicines.

A team of doctors was constituted under the guidance of Dr. Suresh Patankar. This team comprised of Vd. Hrishikesh Rangnekar, physician Dr Kishore Suryawanshi, Dr Praveen Soni, immunity specialist Dr Kalpana Joshi and immunity scientist Dr Tejas Shah. This team designed the clinical trial protocol for the treatment of COVID-19 patients.

This protocol includes almost all the internationally/globally applicable test parameters. This included tests for Viral Load (wherein the exact number of viral counts in an infected individual is determined. This test is completely different than the currently conducted RT-PCR or CT Value tests), TCell (th-1, th-2, th-17 ils-6), NK Cell, IGG, IGM, B Lymphocytes, Antibodies, D Dimer and many others.

To have such a kind of Ayush protocol on Corona published in Nature's Trial Journal is a matter of great joy. This also highlights the necessity of applying modern test parameters while conducting research in ayurveda or Ayush.

This story is provided by BusinessWire India. will not be responsible in any way for the content of this article. (/BusinessWire India)

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

NationalTwo parallel govt jobs land Bihar postal accountant in jail for two years

Cricket"He has all the experience to fall back on...": Skipper Stokes on Dawson's return to Tests after 8 years

EntertainmentDevotional singer Lakhbir Singh Lakha offers prayers at Ujjain's Mahakaleshwar temple, says "I am very lucky"

NationalEnsure strict vigil for CET exams on July 26, 27, says Haryana CM Saini

BusinessIndustry Giant "UNIPACK Corrugated" enters India's ₹50,000 crore Packaging Market through Strategic Acquisition of Congzhou Machinery

Business Realted Stories

BusinessTRAI convenes joint committee of regulators on issues of spam and cyber fraud

BusinessOver Rs 28,996 crore loans given to SC, ST and women under Stand-up India scheme: FM Sitharaman

BusinessDixon Technologies’ profit declines 39 pc sequentially to Rs 280 crore in Q1

BusinessFree Trade Agreement, investment treaty on radar as PM Modi visits Maldives this week

BusinessNPAs of public sector banks declined from 9.1 pc to 2.58 pc: Union Minister